HOLTUG LARS

Track

Insider profile

HOLTUG LARS's trades of Ascendis Pharma A/S's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
396.67
Quantity 54,068 -31.5%
Value US$1,174,717
Transaction date
Proposed sale
Price
29.75
Quantity 53,773
Value US$4,962,785
Transaction date
Proposed sale
Price
124.75
Quantity 23,756
Value US$3,649,655
Transaction date
Proposed sale
Price
152.12
Quantity 1,470
Value US$223,623
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-03 2026-09-02
S Sale
54,068 -31.5%
396.67
US$1,174,717 		54,068 -31.5% 396.67 US$1,174,717
2026-09-02 2026-09-02
PrS Proposed sale
53,773
29.75
US$4,962,785 		53,773 29.75 US$4,962,785
2026-03-02 2026-03-02
PrS Proposed sale
23,756
124.75
US$3,649,655 		23,756 124.75 US$3,649,655
2025-03-04 2025-03-04
PrS Proposed sale
1,470
152.12
US$223,623 		1,470 152.12 US$223,623
2024-03-01 2024-03-01
PrS Proposed sale
653
147.76
US$96,487 		653 147.76 US$96,487